A reduced insulin clearance has been recently identified as a major pathogenetic mechanism of diabetes progression [43,44,45,46] and is typically associated with insulin-resistance [45,46,47], visceral obesity [47,48,49,50,51], and non-alcoholic fatty liver disease [46,47,51,52,53]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.